Cephalosporins
Range
Broad-Spectrum Antibiotics for Effective Infection Management
Our Cephalosporins Range provides a comprehensive portfolio of oral and injectable antibiotics designed to treat bacterial infections across a broad spectrum. With formulations spanning 2nd, 3rd, and 4th generation cephalosporins, the range is designed for both community-acquired and hospital-acquired infections. The portfolio offers standalone molecules and advanced combinations, ideal for treating mild to severe infections, including those caused by resistant organisms.
Product Range
- Cephalosporins Oral Tablets
- Cephalosporins Dry Syrups & Suspensions
- Cephalosporins Injectable Formulations
Respiratory Tract Infections
Cephalosporins are effective in treating respiratory infections, including pneumonia, bronchitis, and sinusitis, often caused by both Gram-positive and Gram-negative bacteria.
Urinary Tract Infections (UTIs)
Common urinary tract infections caused by susceptible bacteria are managed efficiently with our cephalosporins, offering a broad range of coverage.
What It Fixes
Skin & Soft Tissue Infections
Provides effective treatment for a wide variety of skin and soft tissue infections, including cellulitis, abscesses, and wounds.
Intra-abdominal and Gynaecological Infections
Cephalosporins help manage infections arising from intra-abdominal and gynaecological infections where cephalosporin therapy is appropriate.
Bone, Joint, and Post-Surgical Infections
Effective against bone and joint infections, as well as infections following orthopaedic surgeries and implants.
Severe Systemic Infections (Including Sepsis)
The advanced cephalosporins are used in the management of severe systemic infections, including sepsis, based on clinical judgment and susceptibility patterns.
Infections Caused by Resistant Organisms
Advanced formulations with beta-lactamase inhibitors enhance activity against susceptible beta-lactamase–producing organisms.
How It Works
Bacterial Cell Wall Synthesis Inhibition
Cephalosporins work by inhibiting the synthesis of bacterial cell walls, leading to the rapid destruction of the bacteria and preventing further infection spread.
Generation-wise Therapeutic Flexibility
Our range spans 2nd, 3rd, and 4th generation cephalosporins, providing flexibility to choose the appropriate drug based on infection type, severity, and resistance patterns.
High Tissue Penetration
Cephalosporins provide high tissue penetration, ensuring that therapeutic drug levels reach the site of infection, supporting effective antimicrobial activity.
Combination Therapy for Resistant Infections
Our combination formulations (e.g., with sulbactam) enhance activity against beta-lactamase–producing organisms by protecting the antibiotic from enzymatic degradation, supporting treatment of certain hospital-acquired and complicated infections.
Seamless Oral to Injectable Therapy
Cephalosporins in both oral and injectable forms ensure treatment continuity from the hospital to the home, improving compliance and reducing hospital stays.
Key Features
Broad-Spectrum Coverage
Effective against both Gram-positive and Gram-negative bacteria, ideal for empirical therapy and targeted treatments.
Flexible Therapy Options
Available in oral tablets, dry syrups, suspensions, and injectables to suit diverse patient needs, from mild to severe infections.
Advanced Combination Formulations
Incorporates beta-lactamase inhibitors to enhance activity against susceptible beta-lactamase–producing organisms.
Seamless Continuity of Care
Transition smoothly from injectable to oral therapy, improving patient compliance and reducing hospital stay durations.
High Tissue Penetration
Achieves therapeutic concentrations at infection sites, supporting effective antimicrobial activity.
Paediatric and Adult Use
Suitable for both adult and paediatric care with specific formulations to support safe treatment in children.